摘要
目的：总结经尿道前列腺电切术（TURP）治疗高危良性前列腺增生症（BPH）患者的临床疗效和安全性。方法对112例高危BPH患者应用经尿道前列腺电切术治疗的临床资料进行分析。结果全部患者均顺利完成手术，手术时间40～110 min，术中出血量平均约80 mL，无输血，无前列腺电切综合征（TURS）发生。随访3～12个月，全部患者术后排尿功能恢复良好，无1例真性尿失禁及继发性出血。国际前列腺症状评分（IPSS）由29.6分下降至7.3分，最大尿流率（Qmax）由7 mL/s增至20 mL/s，残余尿量（PVR）由158 mL降至20 mL。治疗前后的IPSS、Qmax、PVR对比，差异有统计学意义。结论对高危BPH患者应用经尿道前列腺电切术（TURP）安全有效，个体化的治疗方案及严格的围手术期处理是治疗成功的关键。
Objective To investigate the efficacy and safetyof high risk benign prostate hyperplasia（BPH）treated with TURP. Methods The clinical experiences of TURP treatment in 112 cases of high risk benign prostate hyperplasia were analyzed. Results All operations were performed smoothly.The operating time was 40-110 min, no blood transfusion, no transurethral resection syndrome（TURS）. With follow up of 3-12 months,all patients had fluent urination but no urinary incontinence and secondary hemorrhage. The International Prostate Symptom Score（IPSS）were decreased from 29.6 to 7.3.Maximal flow rate（Qmax）increased from 7mL/min to 20mL/min. Prostate Volume Reduction（PVR）from 158mL to 20mL .Therewere significant diferenceinIPSS, Qmax ,PVR,between pre-operation and post-operation. Conclusion TURP is a safe and effective therapy to high risk patients with benign prostate hyperplasia. The Individual treatment and systematic treatment during perioperafion are the keys to the success.
出处
《中国医药指南》
2014年第12期31-32,共2页
Guide of China Medicine
